NEO100 perillyl alcohol: Phase I/IIa started

NeOnc began an open-label, international Phase I/IIa trial to evaluate 96, 144, 192 and 288 mg intranasal NEO100 given 4 times daily via a nebulizer and nasal mask for 6 months in about 40 patients. F...